My Cart

SMAC

SMAC Overview

English NameDiablo homolog, mitochondrialApproved Drugs0
Drugs in Clinical Trials1Target SynonymDirect IAP-binding protein with low pI,Second mitochondria-derived activator of caspase,Smac,Diablo IAP-Binding Mitochondrial Protein
Highest Development StagePhase 1 Clinical
English NameDiablo homolog, mitochondrial
Target SynonymDirect IAP-binding protein with low pI,Second mitochondria-derived activator of caspase,Smac,Diablo IAP-Binding Mitochondrial Protein
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 1 Clinical

SMAC Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeatureOrder Now
DIO-H5129
Human
E. coli
Human SMAC / Diablo Protein, His Tag
Add to Cart
Total: 1
  • 1

SMAC Background

Diablo homolog, mitochondrial (DIABLO) is also known as direct IAP-binding protein with low pI and second mitochondria-derived activator of caspase (SMAC), which can interact with BIRC2/c-IAP1, BIRC3/c-IAP2, XIAP/BIRC4, BIRC6/bruce and BIRC7/livin. Acting by opposing the inhibitory activity of inhibitor of apoptosis proteins (IAP),DIABLO can also promote apoptosis by activating caspases in the cytochrome c/Apaf-1/caspase-9 pathway. Also, DIABLO inhibits the activity of BIRC6/bruce by inhibiting its binding to caspases. Furthermore, DIABLO is defective in the capacity to down-regulate the XIAP/BIRC4 abundance.

SMAC Synonyms

DIABLO,SMAC

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
BI-891065BI-891065Phase 1 ClinicalBoehringer Ingelheim International GmbhCarcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Neoplasms
Details
  • Overview
  • Product List
  • Clinical Drug Information